CENTER VALLEY, Pa.--(BUSINESS WIRE)--Aesculap announced today that it has acquired the assets of Aragon Surgical, Inc. Aragon Surgical specializes in advanced radio frequency (RF) electrosurgical instruments for tissue fusion and cutting. The Caiman® instruments are the only RF devices on the market with an articulating jaw-technology, which allows the surgeon unparalleled maneuverability at the surgical site. The Caiman advanced energy product line complements Aesculap’s already extensive line of endoscopic and open surgical instruments, positioning the company to better meet the needs of the changing medical community.
“We are very excited about the inclusion of the Caiman product line into the Aesculap family of surgical instruments. The Caiman’s unique articulating jaw design and proprietary Lektrafuse® technology provide improved clinical benefits. This acquisition will widen the scope of our surgical instrument portfolio and enhance Aesculap’s line of products to improve patient care,” said Chuck DiNardo, President of Aesculap, Inc.
“This transaction will allow for increased distribution of the Caiman product line,” said Roseanne Varner, President and Chief Executive Officer of Aragon, “while providing our customers with the continued high quality service they have come to expect.”
To learn more about the Caiman product line visit www.caimansurgery.com.
About Aesculap, Inc.
Aesculap, Inc., a B. Braun company, founded in 1867 in Tuttlingen, Germany, is the world’s largest and one of the most respected manufacturers of surgical instruments and sterilization container systems. Aesculap is a leading privately-owned manufacturing company, passionately committed to providing high-quality, innovative products and services to all surgical disciplines, with particular focus in the fields of General, Neuro, Spine and Orthopaedics. For more information, contact Aesculap Customer Service at 1-800-282-9000 or visit www.aesculapusa.com
About B. Braun
B. Braun is a leading manufacturer of infusion therapy and pain management products with an environmentally-friendly focus. Guided by the company’s “Sharing Expertise®” philosophy, B. Braun addresses the critical issues of infection prevention, medication safety and environmental responsibility by promoting best practices that help clinicians reduce medication errors, prevent healthcare-acquired infections (HAIs) and achieve sustainability objectives.
Consistently recognized by Frost & Sullivan and KLAS for its medical technology and support services, B. Braun employees share their knowledge with colleagues and customers to improve working processes in hospitals and medical practices and to enhance the safety of patients and healthcare professionals. For more information, call 800-227-2862, e-mail us at inquiry.us@bbraun.com or visit B. Braun at www.bbraunusa.com.
Contacts
Aesculap, Inc. Mark Longenbach Manager, Corporate Communications 1-800-258-1946 mark.longenbach@aesculap.com
